A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Nimbus Therapeutics
Nimbus Therapeutics
Vividion Therapeutics, Inc.
University of Pittsburgh
Marengo Therapeutics, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Blokhin's Russian Cancer Research Center